Dabigatran versus warfarin for the prevention of stroke in Chinese patients with nonvalvular atrial fibrillation: Chinese subpopulation analysis of RE-LY
X Gao, YM Yang, J Zhu, Y Dai, HQ Tan - … xin xue Guan Bing za zhi, 2016 - europepmc.org
Objective: This analysis was performed to evaluate the efficacy in stroke prevention and
safety of dabigatran in Chinese nonvalvular atrial fibrillation (NVAF) patients enrolled in RE …
safety of dabigatran in Chinese nonvalvular atrial fibrillation (NVAF) patients enrolled in RE …
A comparison of dabigatran with warfarin for stroke prevention in atrial fibrillation in an Asian population
LB Yap, DTS Eng, L Sivalingam… - Clinical and Applied …, 2016 - journals.sagepub.com
Background: The Asian population with atrial fibrillation (AF) have a higher risk of stroke
than the caucasian population and a higher risk of intracranial bleeding when …
than the caucasian population and a higher risk of intracranial bleeding when …
Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong
JCS Ho, AM Chang, BP Yan, CM Yu, YY Lam… - Clinical …, 2012 - Wiley Online Library
Background: Dabigatran is an oral direct thrombin inhibitor recently approved for stroke
prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of …
prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of …
Cardiovascular, bleeding, and mortality risks of dabigatran in Asians with nonvalvular atrial fibrillation
Background and Purpose—Whether dabigatran is associated with different risks of
cardiovascular, bleeding events, and mortality from warfarin in Asian patients with …
cardiovascular, bleeding events, and mortality from warfarin in Asian patients with …
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
Background Little is known about the comparative effectiveness and safety of non–vitamin K
antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation …
antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation …
Continuation of dabigatran therapy in “real-world” practice in Hong Kong
MH Ho, CW Ho, E Cheung, PH Chan, JJ Hai, KH Chan… - PloS one, 2014 - journals.plos.org
Background Dabigatran, an oral direct thrombin inhibitor, possesses several advantages
over warfarin that can in principle simplify the management of stroke prevention in atrial …
over warfarin that can in principle simplify the management of stroke prevention in atrial …
Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation–sub-analysis in Japanese population in RE-LY trial–
M Hori, SJ Connolly, MD Ezekowitz, PA Reilly… - Circulation …, 2011 - jstage.jst.go.jp
Background: RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) is an
international multicenter study (18,113 patients from 967 centers in 44 countries) that …
international multicenter study (18,113 patients from 967 centers in 44 countries) that …
[HTML][HTML] Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: a single-center observational study
M Naganuma, T Shiga, T Nagao, A Suzuki… - Journal of arrhythmia, 2017 - Elsevier
Background In “real-world” practice, anticoagulant therapy is indicated for patients whose
clinical profiles are not addressed in randomized clinical trials. We assessed the …
clinical profiles are not addressed in randomized clinical trials. We assessed the …
[HTML][HTML] Dabigatran for Japanese patients with atrial fibrillation and prior stroke: a subgroup analysis of the J-Dabigatran Surveillance program
M Yasaka, S Uchiyama, H Atarashi, K Okumura… - Journal of Stroke and …, 2020 - Elsevier
Background: The study objective was to evaluate long-term safety and effectiveness of
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation
KH Lee, HW Park, N Lee, DY Hyun, J Won, SS Oh… - Ep …, 2017 - academic.oup.com
Aims We aim to determine the optimal dose of dabigatran in Korean patients with atrial
fibrillation (AF). Methods and results We analysed 1834 patients with non-valvular AF …
fibrillation (AF). Methods and results We analysed 1834 patients with non-valvular AF …
相关搜索
- atrial fibrillation stroke prevention
- atrial fibrillation safety of dabigatran
- atrial fibrillation japanese patients
- subpopulation analysis warfarin for the prevention
- chinese patients warfarin for the prevention
- subpopulation analysis chinese patients
- safety of dabigatran stroke prevention
- atrial fibrillation subgroup analysis
- safety of dabigatran warfarin in patients
- korean patients dabigatran for the prevention
- asian population stroke prevention
- japanese population warfarin in patients
- chinese patients fibrillation project
- atrial fibrillation asian population
- bleeding risk dabigatran for the prevention
- atrial fibrillation bleeding risk